Dr. Lane is a clinical professor of ophthalmology, University of Minnesota School of Medicine, St. Paul ...
Steve Swalgen is national director of lab business, Santinelli International, Hauppauge, NY. Swalgen also is an advisory board member of the Optical Laboratory Association (OLA) and has developed and ...
IRIS Registry data showed no change in anti-VEGF frequency, vision, or retinal thickness after patients with DME began a GLP-1RA. The study was prompted by an observation from Nagalamadaka's principal ...
Teprotumumab-trbw (Tepezza; Amgen) has demonstrated clinical benefit in thyroid eye disease (TED), but less is known about ...
In the latest episode of The Retina TL;DR with Dr. Weng—Part 2 of a special two-part series—host Christina Y. Weng, MD, MBA, ...
October 16, 2026, delivered 3 ophthalmic FDA approvals that, taken together, touch nearly every corner of the eye care ...
Keith Warren, MD | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern ...
Docking the trailing haptic is the step where surgeons most often struggle with the Yamane technique, according to Murtaza K.
Omur Ucakhan, MD, explains why artificial tears are not interchangeable and how dry eye phenotype should guide formulation ...
The epidemiology, inflammatory pathophysiology, diagnosis, and treatment of diabetic macular edema are discussed during ...
CLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo. The release noted that brepocitinib demonstrated consistent benefits in ...
How should clinicians recognize Demodex blepharitis, and which specialists should be looking for it? These questions framed a recent Ophthalmology Times Clinical Forum in New Orleans, Louisiana: “ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results